H&R Wasag stays positive as oil prices bite in pharma
Oil price fluctuations had the expected impact of dampening profits in H&R Wasag's key chemical-pharmaceutical raw materials business during 2007.
Oil price fluctuations had the expected impact of dampening profits in H&R Wasag's key chemical-pharmaceutical raw materials business during 2007.
An investigation in the aftermath of a fire and explosion at one of Cambrex' US plants last year has found the firm in breach of several safety regulations and the company will be fined accordingly.
Covance has emerged triumphant in the latest episode of a long-lasting saga over a new US animal testing lab that it is building in Chandler, Arizona.
Jubilant Organosys, India's largest custom research and manufacturing services (CRAMS) provider, has scored new contracts to the tune of $92m for the year thus far as its business continues to gather momentum.
Biotage has announced plans to shift its business focus to the environmental analysis sector - an industry on the rise as soaring world population demands more efficient and safe laboratory technologies to deal with waste, hazardous materials and...
Packaging giant Gerresheimer crowned its first year as a public company with a leap in profits for the fourth quarter of 2007, helped by its acquisition of plastic specialist Wilden Group.